Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2020

Mar 3, 2020

284_dirs_2020-03-03_fc395334-b452-4555-9d81-b9e87a06b2f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-02-28

Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-28 Common Stock A 1659 $76.56 Acquired 4513.879 Direct

Footnotes

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019.

F2: Holdings include shares acquired in dividend reinvestment transactions.